Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jazz Pharmaceuticals (DE:J7Z)
FRANKFURT:J7Z
Jazz Pharmaceuticals (J7Z) Ownership - Who Owns Jazz Pharmaceuticals?
1 Followers
Jazz Pharmaceuticals (J7Z) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
4.96% Other Institutional Investors
95.04% Public Companies and
Individual Investors
The ownership structure of Jazz Pharmaceuticals (DE:J7Z) stock is a mix of institutional, retail and individual investors. Approximately 4.96% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 95.04% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 08, 2024 | Patricia Carr Svp & Cao | Sold | $438448 |
| Mar 05, 2024 | Philip L Johnson Evp & Chief Financial Officer | Bought | $1435800 |
| Dec 06, 2023 | Mark Douglas Smith Director | Sold | $49736 |
| Dec 06, 2023 | Jennifer E. Cook Director | Sold | $49736 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Sold | $470229 | |
| Dec 31, 2023 | Sold | $653130 | |
| Dec 31, 2023 | Bought | $2439705 | |
| Dec 31, 2023 | Bought | $11121168 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 24,938 | Insider | ― | 2,528,713 | |
| 18,385 | Insider | ― | 1,864,239 | |
| 38,484 | Insider | ― | 3,902,278 | |
| 39,738 | Insider | ― | 4,029,433 | |
| 102,821 | Insider | ― | 10,426,049 | |
| 13,705 | Insider | ― | 1,389,687 | |
| 22,118 | Insider | ― | 2,242,765 | |
| 8,290 | Insider | ― | 840,606 | |
| 429,809 | Insider | ― | 43,582,633 | |
| 10,444 | Insider | ― | 1,059,022 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 119,480 | Institution | ― | 12,966,448 | |
| 200,463 | Institution | ― | 21,755,047 | |
| 1,500 | Institution | ― | 162,786 | |
| 133,600 | Institution | ― | 14,498,806 | |
| 550,130 | Institution | ― | 59,702,308 | |
| 225,000 | Institution | ― | 24,417,900 | |
| 300 | Institution | ― | 32,557 | |
| 16,845 | Institution | ― | 1,828,087 | |
| 34,962 | Institution | ― | 3,794,216 | |
| 15,370 | Institution | ― | 1,668,014 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Jazz Pharmaceuticals (DE:J7Z)?
According to the latest TipRanks data, approximately 4.96% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 95.04% is held by retail investors.
What percentage of Jazz Pharmaceuticals (DE:J7Z) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.96% of Jazz Pharmaceuticals (DE:J7Z) stock is held by institutional investors.
What percentage of Jazz Pharmaceuticals (DE:J7Z) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.04% of Jazz Pharmaceuticals (DE:J7Z) stock is held by retail investors.
Who owns the most shares of Jazz Pharmaceuticals (DE:J7Z)?
Iain Mcgill owns the most shares of Jazz Pharmaceuticals (DE:J7Z).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.